Head-To-Head Comparison: NantHealth (NASDAQ:NH) Versus AcuityAds (NYSE:ATY)
Head-To-Head Comparison: NantHealth (NASDAQ:NH) Versus AcuityAds (NYSE:ATY)
NantHealth (NASDAQ:NH – Get Rating) and AcuityAds (NYSE:ATY – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, valuation, earnings and profitability.
NantHealth（纳斯达克股票代码：NH — 获取评级）和 AcuityAds（纽约证券交易所代码：ATY — 获取评级）都是小型医疗公司，但哪只是优势股？我们将根据两家公司的风险强度、分析师建议、股息、机构所有权、估值、收益和盈利能力对比这两家公司。
Insider and Institutional Ownership
内部所有权和机构所有权
4.5% of NantHealth shares are held by institutional investors. Comparatively, 8.7% of AcuityAds shares are held by institutional investors. 61.3% of NantHealth shares are held by insiders. Comparatively, 12.0% of AcuityAds shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
4.5％的NantHealth股票由机构投资者持有。相比之下，8.7％的AcuityAds股票由机构投资者持有。61.3％的NanThealth股票由内部人士持有。相比之下，有12.0％的AcuityAds股票由内部人士持有。强大的机构所有权表明对冲基金、捐赠基金和大型基金经理认为，从长远来看，股票的表现将优于市场。
Volatility & Risk
波动性与风险
NantHealth has a beta of 1.82, meaning that its stock price is 82% more volatile than the S&P 500. Comparatively, AcuityAds has a beta of 1.26, meaning that its stock price is 26% more volatile than the S&P 500.
NantHealth的beta值为1.82，这意味着其股价的波动性比标准普尔500指数高82％。相比之下，AcuityAds的beta值为1.26，这意味着其股价的波动性比标准普尔500指数高26％。
Analyst Ratings
分析师评级
This is a summary of current ratings and price targets for NantHealth and AcuityAds, as reported by MarketBeat.
据MarketBeat报道，这是NantHealth和AcuityAds当前的评级和目标价格的摘要。
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| NantHealth | 0 | 0 | 0 | 0 | N/A |
| AcuityAds | 0 | 0 | 5 | 0 | 3.00 |
| 卖出评级 | 保持收视率 | 买入评级 | 强劲的买入评级 | 评分分数 | |
| NanHealth | 0 | 0 | 0 | 0 | 不适用 |
| acuityAds | 0 | 0 | 5 | 0 | 3.00 |
AcuityAds has a consensus target price of $3.43, suggesting a potential upside of 114.29%. Given AcuityAds' higher probable upside, analysts plainly believe AcuityAds is more favorable than NantHealth.
AcuityAds的共识目标价格为3.43美元，表明潜在的上涨空间为114.29％。鉴于AcuityAds可能有更高的上行空间，分析师显然认为AcuityAds比NantHealth更有利。
Earnings & Valuation
收益与估值
This table compares NantHealth and AcuityAds' top-line revenue, earnings per share and valuation.
该表比较了NantHealth和AcuityAds的营收、每股收益和估值。
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| NantHealth | $67.00 million | 0.16 | -$67.78 million | ($7.65) | -0.18 |
| AcuityAds | $121.04 million | 0.75 | -$580,000.00 | ($0.01) | -160.00 |
| 总收入 | 价格/销售比率 | 净收入 | 每股收益 | 市盈率 | |
| NanHealth | 6,700 万美元 | 0.16 | -6778 万美元 | （7.65 美元） | -0.18 |
| acuityAds | 1.2104 亿美元 | 0.75 | -580,000.00 美元 | (0.01 美元) | -160.00 |
AcuityAds has higher revenue and earnings than NantHealth. AcuityAds is trading at a lower price-to-earnings ratio than NantHealth, indicating that it is currently the more affordable of the two stocks.
AcuityAds 的收入和收益高于 nanThealth。AcuityAds的交易市盈率低于NantHealth，这表明它目前是这两只股票中更实惠的一只。
Profitability
盈利能力
This table compares NantHealth and AcuityAds' net margins, return on equity and return on assets.
该表比较了NantHealth和AcuityAds的净利润率、股本回报率和资产回报率。
| Net Margins | Return on Equity | Return on Assets | |
| NantHealth | -101.16% | N/A | -39.91% |
| AcuityAds | -1.39% | -5.84% | -4.46% |
| 净利润 | 股本回报率 | 资产回报率 | |
| NanHealth | -101.16% | 不适用 | -39.91% |
| acuityAds | -1.39% | -5.84% | -4.46% |
Summary
摘要
AcuityAds beats NantHealth on 9 of the 13 factors compared between the two stocks.
在两只股票比较的13个因素中，AcuityAds在9个因素上击败了NantHealth。
About NantHealth
关于 nanHealth
(Get Rating)
（获取评分）
NantHealth, Inc. is an evidence-based, personalized healthcare company, which engages in the provision of treatment for critical diseases such as cancer. The firm empowers treatment decisions, improves patient outcomes, validates treatment options, enables high-quality care, lowers costs, ensures appropriate reimbursement, and streamlines implementation and deployment. The company was founded by Patrick Soon-Shiong in July 2010 and is headquartered in Morrisville, NC.
NantHealth, Inc. 是一家基于证据的个性化医疗保健公司，致力于为癌症等关键疾病提供治疗。该公司支持治疗决策，改善患者预后，验证治疗方案，提供高质量的护理，降低成本，确保适当的报销，并简化实施和部署。该公司由帕特里克·顺雄于2010年7月创立，总部位于北卡罗来纳州莫里斯维尔。
About AcuityAds
关于 AcuityAds
(Get Rating)
（获取评分）
AcuityAds Holdings, Inc. engages in the provision of digital advertising solutions. It operates through the following geographical segments: Unites States, Canada, and Europe and Other. The company was founded by Tal Hayek, Nathan Mekuz, Rachel Kapcan, and Joe Ontman on October 9, 2009 and is headquartered in Toronto, Canada.
AcuityAds Holdings, Inc. 从事数字广告解决方案的提供。它通过以下地理区域运营：美国、加拿大和欧洲及其他。该公司由塔尔·哈耶克、内森·梅库兹、雷切尔·卡普坎和乔·昂特曼于2009年10月9日创立，总部位于加拿大多伦多。
Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with MarketBeat.com's FREE daily email newsletter.
接收 NanHealth Daily 的新闻和收视率 -在下面输入您的电子邮件地址，通过Marketbeat.com的免费每日电子邮件时事通讯接收NantHealth及相关公司最新新闻和分析师评级的简明每日摘要。